Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Pharvaris N.V. publishes a filing, an earnings call transcript or a press release.

Get PHVS alerts

About Peng Lu

Peng Lu has spoken on 2 investor events across 1 company, most recently for Pharvaris N.V. on November 9, 2026. Pharvaris N.V. is classified in the Biotechnology industry within the Healthcare sector.

Peng Lu on recent calls

“I've been working in HE over a decade, and always our, you know, motivation is how we can translate the novel science to really help the patients and really address what the patients need.”
Other, Guggenheim 3rd Annual Healthcare Innovation Conference ·
“Actually, from the placebo part, maybe someone viewed that actually the placebo, actually, if we look at the placebo arm, the attack rate is around 2.6 attack per month compared to other HE pivotal trials, actually very well within the range between 2 and 2.3 other pivotal trials.”
Other, Wells Fargo 21st Annual Healthcare Conference ·

Affiliation history

Company network

Recent activity